1
acetate and hexane. Yield was 92%; mp 155-156°C. H NMR spectrum, δ, ppm (J, Hz): 4.05 (2H, s, SO2CH2);
4.19 (2H, d, J = 6.5, NCH2); 7.24-7.35 (5H, m, ArH); 7.93 (1H, t, J = 6.5, NH). 13C NMR spectrum, δ, ppm:
46.4 (NHCH2); 56.9 (SO2CH2); 126.9 (p-CAr); 127.6 (o/m-CAr); 128.0 (m/o-CAr); 137.9 (ipso-CAr); 164.6 (CO).
Mass spectrum, m/z (Irel, %): 229 [M]+ (5), 210 (10), 106 (100), 91 (50), 77 (18). Found, %: C 47.32; H 5.02;
N 6.16. C9H11NO4S. Calculated, %: C 47.15; H 4.84; N 6.11.
4-Methoxycarbonyl-2-phenyl-1,2,4,5-tetrahydrobenzo[d][1,2]thiazepine 3,3-Dioxide (10a).
A
solution of 1,2-bis(bromomethyl)benzene (1.58 g, 6 mmol) in DMF (40 ml) was added during 2 h to a mixture
of sulfonamide 2a (0.91 g, 4 mmol) and potassium carbonate (1.66 g, 12 mmol) in DMF (60 ml) at 65°C. The
mixture was stirred until the end of the reaction (check by TLC). The mixture was diluted with water (150 ml),
acidified with conc. HCl to pH ≤2, and extracted with dichloromethane (3×50 ml). The organic phases were
combined, washed with 2% HCl (5×80 ml), and evaporated to dryness. The product was recrystallized from
ethyl acetate.
Methyl 1-(N-Methyl-N-phenylaminosulfonyl)cyclopropanecarboxylate (11b).
A
solution of
1,2-dibromoethane (1.65 g, 7.7 mmol) in DMF (40 ml) was added during 2 h to a mixture of sulfonamide 2b
(1.94 g, 8 mmol) and potassium carbonate (3.31 g, 24 mmol) in DMF (60 ml) at 65°C, and the mixture was
stirred for a further 24 h. The reaction mixture was then diluted with water (150 ml), acidified with conc. HCl to
pH ≤2, and extracted with dichloromethane (3×50 ml). The organic phases were combined, washed with 2%
HCl (5×80 ml), dried over sodium sulfate, and evaporated to dryness. Yield was 72%, light-yellow oil. 1H NMR
spectrum, δ, ppm: 1.45 (4H, m, CH2CH2); 3.51 (3H, s, NCH3); 3.79 (3H, s, OCH3); 7.30-7.40 (5H, m, ArH).
13C NMR spectrum, δ, ppm: 17.11 (CH2CH2); 40.70 (NCH3); 40.96 (SO2C); 53.00 (OCH3), 126.67 (o/m-CAr);
127.79 (p-CAr); 129.35 (m/o-CAr); 141.48 (ipso-CAr); 168.27 (CO). Mass spectrum, m/z (Irel, %): 269 [M]+ (12),
106 (100), 77 (53), 51 (12), 39 (25). Found, %: C 53.70; H 5.62; N 5.26. C12H15NO4S. Calculated, %: C 53.52;
H 5.61; N 5.20.
1-(N-Methyl-N-phenylaminosulfonyl)cyclopropanecarboxylic Acid (12b). A 10% solution of KOH
(2.8 g, 5 mmol) was added to a boiling solution of ester 8b (1.07 g, 4 mmol) in 50% aqueous ethanol (20 ml).
The solution was heated for a further 10 min, cooled to room temperature, diluted with water (100 ml), and
acidified with HCl to pH ≤2. The obtained suspension was extracted with ethyl acetate (3×50 ml), the organic
phases were combined, dried over sodium sulfate, and evaporated to dryness. The product was recrystallized
1
from a hexane–ethyl acetate mixture. Yield was 86%; mp 150-151°C. H NMR spectrum (DMSO-d6), δ, ppm:
13
1.24 (4H, m, CH2CH2); 3.43 (3H, s, NCH3); 7.27-7.37 (5H, m, ArH). C NMR spectrum (acetone-d6), δ, ppm:
14.4 (CH2CH2); 38.6 (NCH3); 39.0 (SO2C); 125.9 (p-CAr), 126.1 (o/m-CAr); 127.6 (m/o-CAr); 140.4 (ipso-CAr);
167.0 (CO). Mass spectrum, m/z (Irel, %): 255 (32) [M]+, 106 (100), 79 (21), 77 (62), 51 (12), 39 (44). Found, %:
C 51.70; H 5.22; N 5.56. C11H13NO4S. Calculated, %: C 51.75; H 5.13; N 5.49.
REFERENCES
1.
2.
M. D. Mashkovskii, Drugs [in Russian], Vol. 2, Meditsina, Moscow (1986).
A. T. Soldatenkov, N. M. Kolyadina, and I. V. Shendrik, Fundamentals of the Organic Chemistry of
Medicinal Substances [in Russian], Khimiya, Moscow (2001).
3.
4.
S.-U. Kang, W. J. Choi, S. Oishi, K. K. Lee, R. G. Karki, K. M. Worthy, L. K. Bindu, M. C. Nicklaus,
R. J. Fisher, and T. R. Burke, Jr., J. Med. Chem., 50, 1978 (2007).
A. Thorarensen, B. D. Wakefield, D. L. Romero, K. R. Marotti, M. T. Sweeney, G. E. Zurenko,
D. C. Rohrer, F. Han, and G. L. Bryant, Bioorg. Med. Chem. Lett., 17, 2823 (2007).
B. Love, M. Kormendy, and K. M. Snader, Synthesis, 31, 3531 (1966).
5.
6.
7.
S. Rossi and G. Pagani, Ann. Chim. (Rome), 56, 728 (1966).
D. D. Long and A. P. Termin, Tetrahedron Lett., 41, 6743 (2000).
484